CRISPR Therapeutics

In News

Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026? - The Motley Fool

The Motley Fool - Dec 19, 2025

How Investors May Respond To CRISPR Therapeutics (CRSP) Earnings Amid Slow Casgevy Uptake Concerns - simplywall.st

simplywall.st - Dec 20, 2025

CRISPR Therapeutics (CRSP): Revisiting Valuation After Recent Share Price Pullback - Yahoo Finance

Yahoo Finance - Dec 18, 2025

Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now? - Nasdaq

Nasdaq - Dec 19, 2025

Cathie Wood’s Buys And Rumors Aside, Here’s Why Crispr Therapeutics Is A Strong Buy (CRSP) - Seeking Alpha

Seeking Alpha - Dec 04, 2025

Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides - Cleveland Clinic Newsroom

Cleveland Clinic Newsroom - Nov 08, 2025

Is CRISPR Therapeutics AG stock positioned for long term growth - 2025 Key Lessons & Real-Time Chart Pattern Alerts - Улправда

Улправда - Dec 21, 2025

2 Monster Stocks in the Making to Buy and Hold - The Motley Fool

The Motley Fool - Dec 16, 2025

CRISPR Therapeutics: CTX310 De-Risks, CASGEVY Disappoints Amid Takeover Rumors (CRSP) - Seeking Alpha

Seeking Alpha - Dec 02, 2025

CRISPR Therapeutics (CRSP): Reassessing Valuation After a 13% Pullback and Strong Year‑to‑Date Gains - simplywall.st

simplywall.st - Dec 18, 2025

Oppenheimer Reaffirms Outlook on CRISPR Therapeutics (CRSP) After Encouraging Q3 Earnings Performance - Yahoo Finance

Yahoo Finance - Nov 25, 2025

What CRISPR Therapeutics’ (CRSP) Latest Trial Results Mean for Investors - Yahoo Finance

Yahoo Finance - Dec 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment